What is Succinimide Market?
Succinimide, or (CH2)2(CO)2NH, is a natural compound with the formula (CH2)2(CO)2NH. 2,5-Pyrrolidinedione and Succinic acid imide are its chemical names. It's a white, hard powder that's used in a variety of natural syntheses as well as silver plating. Cyclic imide is another name for the compound. It may be caused by ammonium succinate thermal decomposition. Anticonvulsant medications such as ethosuximide, phensuximide, and methsuximide are all used as succinimides.
The market study is being classified by Type (Bio based Succinimide, Polyisobutylene Succinimide and N-Bromosuccinimide), by Application (Anticonvulsant Drugs (Mesuximide, Ethosuximide, and Phensuximide), Oil Additives (Lubricant, Detergent & Dispersants, and Others), Agrochemicals (Fungicides, Pesticides, and Others), Water Soluble Polymers, Liquid Crystal Display, Silver Electroless Plating and Others) and major geographies with country level break-up.
Zhejiang Deqing Yinyuan Chemical Industry Co., Ltd (China), Jiangsu Nanjing Shenning Chemical Co., Ltd. (China), Halides Chemicals Pvt. Ltd. (India), Sigma-Aldrich (United States), MP Biomedicals, LLC (United States), Tokyo Chemical industry Co. Ltd. (Japan), Shandong Tianyu Fine Chemical Co., Ltd. (China), Aurum Pharmatech LLC (United States) and Glentham Life Sciences Ltd. (United Kingdom) are some of the key players profiled in the study.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Global Vendors will contribute to the maximum growth of Global Succinimide market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Succinimide market by Type, Application and Region.
On the basis of geography, the market of Succinimide has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Surging Uses of Succinimide as direct Electroless Silver Plating on Electronic Equipment’s
- Rapid Industrialization coupled with a Growing Population
- High Adoption of Polyisobutylene Succinimides
- Harmful Effects on Human Health
- Increasing Health concerns and Government Expenditure on Healthcare
- Rising Numer of Application of Succinimides
- Government Regulations on Plastics
In February 2019, Strides Pharma Global Pte. Limited received an approval for Ethosuximide Softgel Capsules USP, 250 mg from the United States Food & Drug Administration (USFDA). This approval has allowed Strides Pharma Inc., to strengthen their position in the US market.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Succinimide Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Frequently Asked Questions (FAQ):
1. Which factors would majorly drive the Succinimide Market?
"Surging Uses of Succinimide as direct Electroless Silver Plating on Electronic Equipment’s
" is seen as one of major growth factors of Succinimide Market in years to come.
2. Can we have customized study for Succinimide Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.